CAS 1919888-06-4

Formel: C24H26ClF2N5O2

InChl: InChI=1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1

InChI Key: YQQZZYYQTCPEAS-OYLFLEFRSA-N

SMILES: C[C@@H]1C[C@](CCN1CC2=C(C(=CC=C2)Cl)F)(CC3=C(C=CC(=N3)NC4=NNC(=C4)C)F)C(=O)O

LY3295668

CAS: 1919888-06-4

LY3295668 (AK-01) is a selective inhibitor of Aurora A with Kis of 0.8 nM and 1038 nM for Aurora A and B, respectively.

Formel: C₂₄H₂₆ClF₂N₅O₂

Reinheit: 99.68%

Farbe und Form: Solid

Molekulargewicht: 489.945

Ref: TM-T15815

LY3295668

CAS: 1919888-06-4

LY3295668

Formel: C₂₄H₂₆ClF₂N₅O₂

Reinheit: ≥98%

Molekulargewicht: 489.95

Ref: 54-BUP04292

LY3295668

CAS: 1919888-06-4

Reinheit: 99.68%

Ref: IN-DA01FNPX

LY3295668

Kontrolliertes Produkt

CAS: 1919888-06-4

Formel: C₂₄H₂₆ClF₂N₅O₂

Farbe und Form: Neat

Molekulargewicht: 489.945

Ref: TR-L503230

LY3295668

CAS: 1919888-06-4

LY3295668 is a cytostatic agent that has minimal toxicity. It binds to the fatty acid acyl chains in the bacterial membrane, which prevents the bacteria from synthesizing fatty acids and other lipids. LY3295668 also inhibits transcription of bacterial genes involved in growth factor synthesis and blocks DNA-dependent RNA polymerase activity. This agent has been shown to be effective against a number of tumor xenografts, including skin carcinomas and colon adenocarcinomas, with an effective dose range of 10-100 µg/mL. LY3295668 has also been shown to be effective against probiotic bacteria, such as Lactobacillus acidophilus.

Formel: C₂₄H₂₆ClF₂N₅O₂

Reinheit: Min. 95%

Molekulargewicht: 489.95 g/mol

Ref: 3D-UBD88806